Atlas Trials

Evaluation of Heterologous Fecal microbiotA Transfer in ICU Patients: a FeasibilitY and SafetY StudY

Clinical trial NCT03350178 · TERMINATED

Trial details

NCT number
NCT03350178
Sponsor
MaaT Pharma
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Intensive Care UnitsFecal Microbiota Transplantation
Start date
2018-01-15
Primary completion
2019-02-19
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.